Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional Approach
David B. Gough(Mayo Clinic), Jon A. van Heerden, John R. Goellner(Mayo Clinic), Nick J. Gonchoroff, James M. Naessens(Mayo Clinic in Florida), Timothy O. Wilson(Mayo Clinic in Arizona), John H. Donohue(American Cancer Society), Peter C. O’Brien(Mayo Clinic), Alan J. Schutt
Cited by 389
Related Papers
Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study
|Journal of Clinical Oncology|2005|541
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
|The Lancet Oncology|2009|511
Long-Term Survival After Pancreatoduodenectomy for Pancreatic Adenocarcinoma
|Annals of Surgery|2008|461
Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic Response
|Journal of Clinical Oncology|2006|385
Sentinel Lymph Node Biopsy With Metastasis: Can Axillary Dissection Be Avoided in Some Patients With Breast Cancer?
|Journal of Clinical Oncology|1999|309